Do not be misled by the Activist Group that is attempting to take control of AIM’s Board for the second year in a row. Their efforts could put at risk the Company’s clinical progress and potential to enhance value for shareholders.
AIM is working to bring new therapies to market to address a range of life-threatening cancers, debilitating immune disorders and viral conditions (including Long COVID).
The Company is building on substantial momentum in recent years, and expects to achieve clinical milestones during the remainder of 2023.
Recently added Nancy Bryan as an independent director with deep commercial, marketing, business development and corporate finance expertise.
Seeking an additional independent director with additional diverse perspectives and additive biopharmaceutical expertise.
Lead asset Ampligen continues to fuel a broad pipeline in multiple therapeutic indications.
Expects to achieve key clinical milestones over remainder of 2023.
Expanded supply of Ampligen to continue clinical studies.
Prudently managing finances to ensure cash runway to fund operations during multiple key milestones through the end of 2024.
Several individuals in an “Activist Group” have been engaged in a multi-year effort to disrupt AIM’s business and take over the Board.
The Activist Group - if successful - could put the Company's continued progress at significant risk.
Following failed nomination efforts in 2022, the Group has returned in a campaign partially designed to force AIM shareholders to foot the bill for the Group’s millions of dollars of unpaid expenses from the 2022 campaign.
The Group, which is comprised of interconnected individuals and includes convicted felons, has repeatedly omitted key information and made false and misleading statements. They are not acting in the best interests of all shareholders, have ignored the Company’s Bylaws and have repeatedly lost attempts to get their way in Court.
AIM remains committed to protecting the best interests of all shareholders.
Our Commitment to Privacy
The sponsor of this website, www.SafeguardAIM.com (the “Site”), is AIM ImmunoTech Inc. (the “Sponsor”). We respect and value your privacy. This Privacy Policy is designed to assist you in understanding what information is collected from or about you through this Site and how we use and safeguard that information, as well as to assist you in making informed decisions when using the Site.
The core of our Privacy Policy is this:
We want you to feel safe and comfortable when you use the Site, and we are dedicated to developing and upholding high standards for protecting your privacy. You should read and familiarize yourself with this Privacy Policy and with our Terms and Conditions. If you do not agree with our policies and practices, your choice is not to use the Site. By accessing or using the Site, you agree to this Privacy Policy.
WHAT INFORMATION DO WE COLLECT?
Our Site does not ask you to provide any personally identifiable information. Instead, the Site only collects “clickstream data” that provides information about the type of device and browser you are using, and the website from which you linked to our Site. We may collect this data via “cookies” or other, similar technologies. For more information about cookies, visit http://www.allaboutcookies.org/.
We may use this data in an aggregate, non-personally identifiable way to help us analyze and answer questions like how much time visitors spend on each page of the Site, how visitors navigate throughout the Site and how we may tailor our web pages to better meet the needs of visitors. This information will be used to improve the Site.
DO WE DISCLOSE INFORMATION TO OUTSIDE PARTIES?
We may provide aggregate information to our affiliates or reputable third parties for the purposes described herein.
WHAT ABOUT LEGALLY COMPELLED DISCLOSURE OF INFORMATION?
We may disclose information when we, in good faith, believe that the law requires it or for the protection of our legal rights.
WHAT ABOUT OTHER WEBSITES LINKED TO OUR SITE?
We are not responsible for the practices employed by websites linked to or from our Site nor the information or content contained therein. Often links to other websites are provided solely as pointers to information on topics that may be useful to the users of our Site. Please remember that your browsing and interaction on any other website, including websites which have a link on our Site, is subject to that website’s own rules and policies. Please review those rules and policies.
CHANGES TO THIS POLICY.
We reserve the right to make changes to this Privacy Policy from time to time. Revisions will be posted on this page. We suggest you check this page occasionally for updates. Any continued use of the Site after the effective date of any modification to the Privacy Policy will be deemed to be an agreement to the modified terms.
PRIVACY OF CHILDREN
The Site is not intended for children under 13 years of age. No one under age 13 may provide any personal information to or on the Site. We do not knowingly collect personal information from children under 13. If you are under 13, do not use or provide any information on this Site or on or through any of its features/register on the Site, use any of the interactive or public comment features of this Site, or provide any information about yourself to us, including your name, address, telephone number, email address, or any screen name or user name you may use. If we learn we have collected or received personal information from a child under 13 without verification of parental consent, we will delete that information. If you believe we might have any information from or about a child under 13, please contact us at aim@longacresquare.com.
CONTACTING US.
If you have any questions about this Privacy Policy, the practices of the Site, or your dealings with the Site, you can contact aim@longacresquare.com.
Persons who access the information made available by AIM ImmunoTech Inc. (together with its affiliates, “AIM” or “we” or “us”) via this website (the “website”) agree to the following:
While the material on this website is often about investments, none of it is offered as investment advice. For members of the public, this means that neither the receipt nor the distribution of information through this website constitutes the formation of an investment advisory relationship, or any similar client relationship. The materials on this website are for informational purposes only and may not be relied on by any person for any purpose and are not, and should not be construed as investment, financial, legal, tax or other advice, recommendation or research.
This website may contain forward-looking statements on our current expectations and projections about future events. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” “thinks,” “seeks,” “targets,” “forecasts,” “could” or the negative of such terms or other variations on such terms or comparable terminology. Similarly, statements that describe AIM’s objectives, plans or goals are forward-looking. Any forward-looking statements are based on AIM’s current intent, belief, expectations, estimates and projections. These statements are not guarantees of future performance and involve risks, uncertainties, assumptions and other factors that are difficult to predict and that could cause actual results to differ materially. Accordingly, you should not rely upon forward-looking statements as a prediction of actual results and actual results may vary materially from what is expressed in or indicated by the forward-looking statements.
No representation or warranty is given in respect of the correctness of the information contained herein as at any future date. Certain information included in this communication is based on information obtained from third-party sources considered to be reliable. Any projections or analysis provided to assist the recipient of this communication in evaluating the matters described herein may be based on subjective assessments and assumptions and may use one among alternative methodologies that produce different results. Accordingly, any projections or analysis should not be viewed as factual and should not be relied upon as an accurate prediction of future results. In addition, this website may contain performance and other data. Past performance is not indicative of future performance.
This website contains hyperlinks to websites operated by AIM and other parties. AIM does not control the content or accuracy of information on third-party websites and does not otherwise endorse the material placed on such sites.
All information and content on this website is furnished “AS IS,” without warranty of any kind, express or implied. AIM will not assume any liability for any loss or damage of any kind arising, whether direct or indirect, caused by the use of any part of the information provided. AIM and its licensors do not warrant that the content is accurate, reliable or correct; that the website will be available at any particular time or location; that any defects or errors will be corrected; that unauthorized access to or misappropriation of the content will not occur; or that the content is free of viruses or other harmful components. Your use of the website is solely at your risk.
The entire website is subject to copyright with all rights reserved. No permission is granted to copy, distribute, modify, post or frame any text, graphics, video, audio, software code, or user interface design or logos. The information contained herein shall not be published, rewritten for broadcast or publication or redistributed in any medium without prior written permission from AIM.